90 employees
Mabtech supplies a wide range of antibodies to cytokines, immunoglobulins and apolipoproteins.
1986
Mabtech raised undisclosed on December 5, 2019
Investors: EQT Partners/EQT AB
Mabtech raised undisclosed on November 26, 2019
Investors: Merieux Equity Partners and IK Partners